Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 2/20 | 0.46 |
| ▸ | FDPS | P14324 | 1/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | YTHDC1 | Q96MU7 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 10/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.38 |
| ▸ | TSHR | P16473 | 5/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.36 |
| ▸ | USP2 | O75604 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30341176 | 1.00 | GRM5 (0.46) | GRM5FDPSADORA2AADORA1YTHDC1 | |
| Anisole SCHEMBL28293679 | 0.82 | CYP1A2 (0.48) | GRM5LTA4HCYP1A2CYP3A4TSHR | |
| Benzamide SCHEMBL27825323 | 0.79 | GRM5 (0.51) | GRM5FDPSLTA4HCYP1A2CYP3A4 | |
| SCHEMBL2120550 | 0.77 | FDPS (0.45) | FDPSLTA4HCYP1A2CYP3A4TSHR | |
| SCHEMBL28340215 | 0.76 | FDPS (0.44) | FDPSLTA4HCYP1A2CYP3A4TSHR | |
| SCHEMBL1398869 | 0.75 | FDPS (0.41) | FDPSLTA4HCYP1A2CYP3A4TSHR | |
| SCHEMBL9121476 | 0.75 | FDPS (0.41) | FDPSLTA4HCYP1A2CYP3A4TSHR | |
| SCHEMBL10163117 | 0.75 | FDPS (0.51) | FDPSADORA2AADORA1LTA4HCYP1A2 | |
| SCHEMBL31024294 | 0.75 | FDPS (0.51) | FDPSADORA2AADORA1LTA4HCYP1A2 | |
| SCHEMBL5633 | 0.74 | FDPS (0.42) | FDPSLTA4HCYP1A2CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250283063-A1 | NOVEL CRISPR-CAS12I SYSTEMS AND USES THEREOF | HUIDAGENE THERAPEUTICS CO., LTD. (CN) | 2025-09-11 | — | — | US | claimed |
| EP-4514954-A1 | NOVEL CRISPR-CAS12I SYSTEMS AND USES THEREOF | Huidagene Therapeutics (Singapore) Pte. Ltd. (SG) | 2025-03-05 | — | — | EP | claimed |
| EP-4514953-A1 | NOVEL CRISPR-CAS12F SYSTEMS AND USES THEREOF | Huidagene Therapeutics (Singapore) Pte. Ltd. (SG) | 2025-03-05 | — | — | EP | claimed |
| CN-119421948-A | Novel CRISPR-Cas12f system and application thereof | 辉大(上海)生物科技有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-119331309-A | Methyl purine ferulic acid aromatized water magnesite composite material and preparation method and application thereof | 江西广源化工有限责任公司 | 2025-01-21 | — | — | CN | claimed |
| CN-118749029-A | Novel CRISPR-Cas12i system and application thereof | 辉大(上海)生物科技有限公司 | 2024-10-08 | — | — | CN | claimed |
| WO-2024094084-A1 | ISCB POLYPEPTIDES AND USES THEREOF | HUIDAGENE THERAPEUTICS CO., LTD. (CN) | 2024-05-10 | — | — | WO | claimed |
| CN-117820252-A | Preparation and detection methods of nitroreductase hemicyanine dye fluorescent probes and visual application of nitroreductase hemicyanine dye fluorescent probes in clinical bacterial identification | 华北理工大学 | 2024-04-05 | — | — | CN | claimed |
| CN-114410836-B | Kit and method for detecting human parvovirus B19 by integrating sample treatment, nucleic acid extraction and multiplex isothermal amplification | 上海交通大学医学院附属仁济医院 | 2024-03-01 | — | — | CN | claimed |
| CN-117460822-A | Novel CRISPR-Cas12i system and application thereof | 辉大基因治疗(新加坡)私人有限公司 | 2024-01-26 | — | — | CN | claimed |
| US-5985926-A | VIRICIDES OF AMINE COMPOUNDS AND HYDROCARBONS | CELL THERAPEUTICS, INC. (US) | 1999-11-16 | — | — | US | claimed |
| CN-1172417-A | Feed for fishes and shellfishes | PROD DEV RES INST (JP) | 1998-02-04 | — | — | CN | claimed |
| US-5641783-A | ANTIINFLAMMATORY OR IMMUNOSUPPRESSIVE AGENTS | CELL THERAPEUTICS, INC. (US) | 1997-06-24 | — | — | US | claimed |
| EP-0739203-A1 | METHOD FOR TREATING DISEASES MEDIATED BY CELLULAR PROLIFERATION IN RESPONSE TO PDGF, EGF, FGF AND VEGF | CELL THERAPEUTICS, INC. (US) | 1996-10-30 | — | — | EP | claimed |
| CN-1031403-C | Hydroxyalkylfuranyl derivatives | JANSSEN PHARMACEUTICA NV (BE) | 1996-03-27 | — | — | CN | claimed |
| EP-0676958-A1 | METHOD FOR INHIBITING INTRACELLULAR VIRAL REPLICATION | CELL THERAPEUTICS, INC. (US) | 1995-10-18 | — | — | EP | claimed |
| WO-1995019171-A1 | METHOD FOR TREATING DISEASES MEDIATED BY CELLULAR PROLIFERATION IN RESPONSE TO PDGF, EGF, FGF AND VEGF | CELL THERAPEUTICS, INC. (US) | 1995-07-20 | — | — | WO | claimed |
| WO-1995013808-A1 | METHOD FOR SELECTIVELY INHIBITING IL-2 SIGNAL TRANSDUCTION | CELL THERAPEUTICS, INC. (US) | 1995-05-26 | — | — | WO | claimed |
| WO-1995012396-A1 | METHOD FOR INHIBITING INTRACELLULAR VIRAL REPLICATION | CELL THERAPEUTICS, INC. (US) | 1995-05-11 | — | — | WO | claimed |
| WO-1994018192-A1 | PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS | MERCK & CO., INC. (US) | 1994-08-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250283063-A1 | NOVEL CRISPR-CAS12I SYSTEMS AND USES THEREOF | RBM12, PRR12, HM13 | GRM5 4341/4885FDPS 1681/4885ADORA2A 4527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.